Standard Chemical & Pharmaceutical Co. Ltd.

TWSE:1720 Stock Report

Market Cap: NT$11.3b

Standard Chemical & Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Standard Chemical & Pharmaceutical has a total shareholder equity of NT$8.7B and total debt of NT$571.9M, which brings its debt-to-equity ratio to 6.6%. Its total assets and total liabilities are NT$11.8B and NT$3.1B respectively. Standard Chemical & Pharmaceutical's EBIT is NT$1.3B making its interest coverage ratio -31.6. It has cash and short-term investments of NT$1.9B.

Key information

6.6%

Debt to equity ratio

NT$571.94m

Debt

Interest coverage ratio-31.6x
CashNT$1.87b
EquityNT$8.67b
Total liabilitiesNT$3.10b
Total assetsNT$11.77b

Recent financial health updates

Recent updates

Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Jul 29
Standard Chemical & Pharmaceutical (TWSE:1720) Is Increasing Its Dividend To NT$2.70

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13
If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Mar 14
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Mar 01
Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Feb 16
Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Feb 03
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19
Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04
Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22
Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26
Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Financial Position Analysis

Short Term Liabilities: 1720's short term assets (NT$5.3B) exceed its short term liabilities (NT$2.5B).

Long Term Liabilities: 1720's short term assets (NT$5.3B) exceed its long term liabilities (NT$624.7M).


Debt to Equity History and Analysis

Debt Level: 1720 has more cash than its total debt.

Reducing Debt: 1720's debt to equity ratio has reduced from 17% to 6.6% over the past 5 years.

Debt Coverage: 1720's debt is well covered by operating cash flow (220.4%).

Interest Coverage: 1720 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies